Prediction: These Will Be the 3 Largest TSX Stocks in 2022

Focusing on the right growth stocks could see you grow your wealth rapidly in the coming years.

Make a choice, path to success, sign

Image source: Getty Images

If you are a stock market investor who wants to generate massive returns on your investment, you might have been considering investing in technology. The Canadian tech space boasts several high-growth stocks that have made many investors far wealthier due to stellar shareholder returns.

2021 was tougher on the tech sector, seeing several top names trading on the TSX decline in valuations due to the broader pullback in the industry. As the year draws to an end and 2022 looms closer, the tech industry looks like it is back on track to deliver a strong performance again.

I will discuss three stocks that could become massive in 2022 and deliver substantial wealth growth to shareholders to help you understand why you should have the companies on your radar today.

Shopify

Shopify (TSX:SHOP)(NYSE:SHOP) has been on the top of the list for many Canadian investors since it burst onto the scene on the TSX. The Canadian tech stock has delivered multi-bagger shareholder returns with impressive growth in just a few years, overtaking Royal Bank of Canada stock, with its massive $241.20 billion market capitalization, as the top Canadian stock in terms of market cap.

The Canadian growth stock is already the largest TSX stock as of writing. The recent pullback in the tech sector significantly pulled down its share prices before the tech firm began delivering further growth. At writing, Shopify stock is trading for $1,919.64 per share. It is up by over 37% year to date and could deliver further capital gains in the coming years.

Docebo

Docebo (TSX:DCBO)(NASDAQ:DCBO) is a small-cap stock that has not yet seen Shopify stock’s success on the TSX. If you want to beat the broader market by a wide margin, it could be worth your while to consider investing in Docebo stock. The small-cap stock had its initial public offering (IPO) in October 2019, and it is trading for $90.43 per share at writing. It has appreciated by 564% since its debut on the TSX.

A significant reason for the company’s rapid growth is the evolving work environment amid the pandemic. Docebo provides the best-in-class eLearning platform that uses cloud technology and AI to help enterprises train employees. As the remote work culture remains the norm, Docebo stock could have a massive runway to deliver further growth before the tech stock slows down.

Topicus.com

Topicus.com (TSXV:TOI) might be a new entity on the stock market, but it comes with a wealth of experience that Shopify stock and Docebo stock do not possess. The company is a former subsidiary of Constellation Software. The board of directors running Topicus is composed of executives from the former parent company, and they bring plenty of experience into the new company,

Topicus stock will likely lean on the approach of its former parent company to acquire tech companies across various verticals and grow them to enjoy stellar returns. Topicus.com will utilize the same method in the European market to capitalize on the potential there and likely deliver substantial wealth growth to shareholders in the long run. At writing, the stock is trading for $137.04 per share, and it is already up by 116% year to date.

Foolish takeaway

It is impossible to say whether these three tech stocks will soar with certainty as with any investment. However, the changing global landscape and consumer habits strongly indicate that these three tech firms could become massive in the coming years. The year 2022 could see Shopify stock, Docebo stock, and Topicus.com stock appreciate significantly.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Shopify and Topicus.Com Inc. The Motley Fool recommends Constellation Software and Docebo Inc.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »